A key regulator of these processes is Polo-like kinase 1 (PLK1), a proto-oncogene whose overexpression is frequently observed in tumor cells (among others colorectal cancer, lung cancer, breast cancer and melanoma) [56,57,58,59,60,61,62,63,64]. The gene discussed is PLK1; the disease is breast carcinoma.